Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Astellas scraps NSCLC program after look at phase 3 data
Fierce Biotech
Fri, 05/12/17 - 11:47 am
Astellas
non-small cell lung cancer
clinical trials
ASP8273
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Endpoints
Fri, 05/12/17 - 09:40 am
AstraZeneca
clinical trials
durvalumab
Imfinzi
non-small cell lung cancer
Has Merck Lucked Into A $10 Billion Drug?
Forbes
Thu, 05/11/17 - 11:20 am
Merck
Keytruda
bladder cancer
non-small cell lung cancer
OncoMed racks up three straight clinical disasters as lead drug implodes
Endpoints
Mon, 05/8/17 - 10:02 pm
OncoMed
demcizumab
Celgene
clinical trials
non-small cell lung cancer
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:10 am
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials
Fierce Pharma
Tue, 04/4/17 - 11:10 pm
Merck
Bristol-Myers Squibb
Incyte
Keytruda
Opdivo
non-small cell lung cancer
FDA Approves Astra's Lung Cancer Drug
Investopedia
Fri, 03/31/17 - 10:09 pm
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
Mon, 03/27/17 - 09:38 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
Struggling Heat gets a warm response to a snapshot on cancer vax data
Endpoints
Tue, 03/21/17 - 10:06 am
Heat Biologics
vaccines
HS-110
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Investopedia
Mon, 03/20/17 - 10:54 am
Pfizer
Merck KGaA
clinical trials
avelumab
non-small cell lung cancer
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
FDA
Novartis
Zykadia
ALK-positive non-small cell lung cancer
non-small cell lung cancer
Roche
Alecensa
Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Roche
Bristol-Myers Squibb
Tecentriq
non-small cell lung cancer
Opdivo
Label Expansion May Boost Revenues for AstraZeneca’s Tagrisso
Market Realist
Tue, 01/3/17 - 09:49 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca’s Tagrisso Had a Strong Commercial Launch in 2016
Market Realist
Mon, 01/2/17 - 11:57 am
AstraZeneca
Tagrisso
non-small cell lung cancer
Merck kicks off lung-cancer campaign
Medical Marketing and Media
Sat, 12/10/16 - 10:32 am
Merck
Keytruda
DTC advertising
non-small cell lung cancer
AstraZeneca gives fuller picture of Tagrisso's edge in lung cancer
BioPharma Dive
Tue, 12/6/16 - 10:02 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
FDA Grants Merck Priority Review for Keytruda Drug (MRK)
Investopedia
Mon, 11/28/16 - 09:56 am
FDA
priority review
Keytruda
Merck
non-small cell lung cancer
anti-PD-L1
Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
Yahoo/Reuters
Thu, 11/17/16 - 09:47 am
Japan
Bristol-Myers Squibb
Opdivo
drug pricing
non-small cell lung cancer
Ariad Pharma Rises on FDA Decision
Yahoo/24-7 Wall St
Mon, 10/31/16 - 09:37 am
Ariad Pharma
FDA
brigatinib
non-small cell lung cancer
Roche's lung cancer drug wins U.S. approval
Yahoo/Reuters
Tue, 10/18/16 - 10:27 pm
Roche
lung cancer
FDA
Tecentriq
non-small cell lung cancer
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »